GMP Standard Estrogen Prohormone Powder Altrenogest
we factory direct serve steroid powder, steroid oil sarms raw powder and peptides with top quality and best offer. We have professional disgusied packages, desigend according to different countries and different quantities, guarantee the safe delivery. We encourage start from small little quantity to test our quantity and service first.
Wikr:puresteroid
Skype: +8613302415760
Whatsapp: +8613302415760
Email: cindy1114@yccreate.com
Altrenogest Product Name: Altrenogest Synonyms:drc6246;r2267;ru2267;ALLYLTRENBOLONE CAS: 850-52-2 MF: C21H26O2 MW: 310.43 EINECS: 212-703-1 Density: 1.15 g/cm3 Boiling Point: 495.6 °C at 760 mmHg Flash Point: 210.1 °C Storage: store in cool, dry, ventilated place PackAge: Foil Bag or According to Your Requirements. Application :Pharmaceutical and biochemical research,animal conception control Grade: Pharma Grade Appearance: light yellow crystal or powder Usage A synthetic progestational agent used in veterinary medicine for the control of estrus in mares. Usage antineoplastic
Altrenogest Description:
Progestins are primarily produced endogenously by the corpus luteum. They transform proliferative endometrium to secretory endometrium, enhance myometrium hypertrophy and inhibit spontaneous uterine contraction. Progestins have a dose-dependent inhibitory effect on the secretion of pituitary gonadotropins and also have some degree of estrogenic, anabolic and androgenic activity.
Altrenogest (or allyltrenbolone) is a synthetic trienic C21 steroidal progestomimetic, belonging to the 19-nor-testosterone series. It is an orally active (pro)gestagen. Like all steroids, altrenogest acts by its liposolubility by penetrating the target cells where it binds to specific receptors.
Altrenogest Application:
The pharmacodynamic activity of altrenogest has been demonstrated in a number of animal models. The most important effects are the progestomimetic and anti-gonadotrophic effects. Altrenogest also has weak oestrogenic, anabolic and androgenic effects, but has no corticoid or anti-inflammatory effects.
Altrenogest is indicated (labeled) to suppress estrus in mares to allow a more predictable occurrence of estrus following withdrawal of the drug. It is used clinically to assist mares to establish normal cycles during the transitional period from anestrus to the normal breeding season often in conjunction with an artificial photoperiod. It is more effective in assisting in pregnancy attainment later in the transition period. One group of authors (Squires et al. 1983) suggest selecting mares with considerable follicular activity (mares with one or more follicles 20 mm or greater in size) for treatment during the transitional phase. Mares that have been in estrus for 10 days or more and have active ovaries are also considered to be excellent candidates for progestin treatment.
Altrenogest is effective in normally cycling mares for minimizing the necessity for estrus detection, for the synchronization of estrus and permitting scheduled breeding. Estrus will ensue 2-5 days after treatment is completed and most mares ovulate between 8-15 days after withdrawal. Altrenogest is also effective in suppressing estrus expression in show mares or mares to be raced. Although the drug is labeled as contraindicated during pregnancy, it has been demonstrated to maintain pregnancy in oophorectomized mares and may be of benefit in mares who abort due to sub-therapeutic progestin levels.
Altrenogest Usage
In veterinary medicine, altrenogest is used in gilts and mares for zootechnical purposes (oestrus synchronization). The recommended dose for gilts is 20 mg/animal/day given orally for 18 consecutive days, and for mares is 0.044 mg/kg bw/day given orally for 10 to 15 days.
